BioBasics 201: Targeted Biologics for the Non-Scientist

This intensive, two-day course focuses on vaccines, cell therapies, gene therapies, therapeutic antibodies, and RNA-based drugs. Biopharma’s inspiration for the development of targeted biologics is our own human immune system, so we begin with an in-depth explanation of immunology. The course then focuses on the science, challenges, and medical promise of next-generation targeted biologics.

BioBasics 201 is designed for the non-scientist who has taken BioBasics 101 or those who understand the basics of DNA, RNA, proteins, and cell signalling. It is taught by industry experts who explain how these complex drugs work in a simple, engaging manner.

Upon completion of this course you will:

1. Understand the mechanisms the human body uses to protect itself against disease.
2. Have fluency in vaccine platforms and how each protects against diseases, including Covid-19.
3. Understand the rationale of therapeutic antibody mechanisms of action, including monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, and checkpoint inhibitors.
4. Compare and contrast types of DNA- and RNA-based therapies and how each cures disease.
5. Increase your knowledge of cell therapies, including all variations of CAR-based therapies

Please contact William Burrows, Director, Business Operations & Programs, for more information.

 

Program Partner